Medical Properties Trust (NYSE:MPW) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided earnings per share guidance of $1.56-1.58 for the period.
Shares of NYSE:MPW traded up $0.02 during midday trading on Friday, hitting $17.87. The company had a trading volume of 3,282,856 shares, compared to its average volume of 6,615,108. Medical Properties Trust has a twelve month low of $13.98 and a twelve month high of $18.92. The company has a current ratio of 9.37, a quick ratio of 9.37 and a debt-to-equity ratio of 0.82. The stock has a market capitalization of $6.91 billion, a PE ratio of 13.04, a price-to-earnings-growth ratio of 3.27 and a beta of 0.60. The firm’s 50-day moving average is $17.96.
Medical Properties Trust (NYSE:MPW) last issued its earnings results on Thursday, August 1st. The real estate investment trust reported $0.31 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.31. Medical Properties Trust had a return on equity of 7.98% and a net margin of 131.84%. The business had revenue of $192.55 million during the quarter, compared to the consensus estimate of $186.11 million. During the same period last year, the company earned $0.36 EPS. The company’s revenue for the quarter was down 4.6% on a year-over-year basis. As a group, equities research analysts expect that Medical Properties Trust will post 1.57 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Thursday, July 11th. Stockholders of record on Thursday, June 13th were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Wednesday, June 12th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.60%. Medical Properties Trust’s dividend payout ratio is currently 72.99%.
Several equities research analysts have issued reports on the company. Zacks Investment Research cut Medical Properties Trust from a hold rating to a sell rating in a research note on Wednesday, July 17th. ValuEngine cut Medical Properties Trust from a buy rating to a hold rating in a research note on Thursday. SunTrust Banks raised Medical Properties Trust from a hold rating to a buy rating and raised their target price for the stock from $19.00 to $20.00 in a research note on Tuesday, July 2nd. Deutsche Bank raised Medical Properties Trust from a hold rating to a buy rating in a research note on Monday, July 29th. Finally, Stifel Nicolaus raised Medical Properties Trust from a hold rating to a buy rating and raised their price objective for the stock from $18.00 to $19.00 in a research report on Tuesday, July 23rd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of Buy and an average target price of $18.69.
In related news, Director Michael G. Stewart sold 6,830 shares of Medical Properties Trust stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $18.47, for a total value of $126,150.10. Following the completion of the sale, the director now owns 224,615 shares in the company, valued at approximately $4,148,639.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.18% of the stock is owned by company insiders.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Recommended Story: Dead Cat Bounce
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.